Clinical Trial

Biologics for Stricturing Crohn's Diseases

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 11, 2023 (before its estimated January 2024 completion). Its status may not reflect the trial's current state.
Summary
Recent researches have reported that biologics might be also effective for stricturing CD. However, the data were largely retrospective. Prospective studied are needed for evaluate the efficacy of biologics for stricturing Crohn's diseases.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2022-12-08.
Trial Details
NCT Number NCT05645055
Lead Sponsor Jinling Hospital, China
Conditions The Efficacy of Biologics for Stricturing Crohn's Diseases
Enrollment 200 participants
Start Date 2021-01-01
Primary Completion 2024-01 (estimated)
Study Completion 2029-01 (estimated)
Updated on ClinicalTrials.gov 2023-05-11